Joel David Mayersohn - 19 Sep 2025 Form 4/A - Amendment Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by Power of Attorney
Issuer symbol
CTOR
Transactions as of
19 Sep 2025
Transactions value $
$0
Form type
4/A - Amendment
Filing time
01 Dec 2025, 16:10:22 UTC
Date Of Original Report
23 Sep 2025
Previous filing
07 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mayersohn Joel David Director C/O CITIUS ONCOLOGY, INC., 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD /s/ Alexander M. Donaldson, by Power of Attorney 01 Dec 2025 0001588395

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTOR Common Stock Award $0 +300K +1413.23% $0.00 321K 19 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.